ciprofloxacin has been researched along with finafloxacin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higgins, PG; Seifert, H; Stubbings, W; Wisplinghoff, H | 1 |
| Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
| Endermann, R; Goh, F; Körber-Irrgang, B; Kresken, M; Labischinski, H; Leow, P; Stubbings, W; Yong, GC | 1 |
| Dalhoff, A; Schubert, S; Vente, A | 1 |
| Bentley, C; Dalhoff, A; Fischer, C; Lückermann, M; Naber, K; Nowicki, M; Vente, A; Wagenlehner, F; Wohlert, S | 1 |
1 trial(s) available for ciprofloxacin and finafloxacin
| Article | Year |
|---|---|
Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pyelonephritis; Urinary Tract Infections | 2018 |
4 other study(ies) available for ciprofloxacin and finafloxacin
| Article | Year |
|---|---|
Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests | 2010 |
Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
Topics: Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Legionella pneumophila; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Staphylococcus aureus | 2011 |
In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Hydrogen-Ion Concentration; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 2011 |
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Urine | 2017 |